Related Experiment Video
Updated: Jul 6, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Growth hormone and aging: Regulation, signal transduction and replacement therapy
1The Department of Physiology and Pharmacology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157-1083, USA.
Abstract:
It is widely accepted that during the aging process a number of alterations occur at the molecular, cellular, and tissue levels, ranging from an alteration in receptor signal transduction and gene expression to structural and morphological changes in various tissues. There is abundant empirical and scientific evidence to support the hypothesis that many of these aging processes are closely related to a decline in hormone concentrations and/or hormone action, but the etiology of these deficiencies remains elusive. GH and insulinlike growth factor-I (IGF-I) are two potent anabolic hormones that decrease with age and appear to contribute to the loss of tissue function that is associated with normal aging. In this review, age-related changes in the regulation of these hormones are detailed as well as relatively new information on mechanisms of tissue resistance to GH. Finally, the potential use of GH as a therapeutic intervention to delay physiological changes associated with age is discussed.
Insights
Aging is linked to decreased growth hormone (GH) and insulin-like growth factor-I (IGF-I) levels, contributing to tissue dysfunction. This review explores age-related hormonal changes and GH
Area of Science:
- Endocrinology
- Gerontology
- Molecular Biology
Background:
- Aging involves molecular, cellular, and tissue-level alterations, including changes in gene expression and morphology.
- Declining hormone concentrations and/or action are hypothesized to drive many aging processes.
- Growth hormone (GH) and insulin-like growth factor-I (IGF-I) are anabolic hormones that decrease with age, contributing to age-related tissue dysfunction.
Purpose of the Study:
- To review age-related changes in the regulation of GH and IGF-I.
- To discuss new findings on mechanisms of tissue resistance to GH.
- To explore the potential of GH as a therapeutic intervention for age-related physiological changes.
Main Methods:
- Literature review of age-related hormonal changes.
- Analysis of molecular and cellular mechanisms of aging.
- Discussion of therapeutic applications of GH.
Main Results:
- Age-related decline in GH and IGF-I concentrations is a significant factor in aging.
- Mechanisms of GH resistance in aging tissues are being elucidated.
- GH therapy may offer potential to mitigate some age-associated physiological decline.
Conclusions:
- Reduced GH and IGF-I signaling contribute to the functional decline observed in aging.
- Understanding GH resistance mechanisms is crucial for developing effective interventions.
- GH holds potential as a therapeutic strategy to address age-related physiological changes and improve quality of life in older adults.
Related Concept Videos
Healing I: Introduction
TGF - β Signaling Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Signal Transduction: Overview
Typically, signal transduction involves three...
Regulation of Hormone Secretion
Humoral stimuli,...
Cellular Adaptation II: Hypertrophy